Background
Noninvasive assessment of dynamic changes in liver blood flow, perfusion, and oxygenation using MRI may allow detection of subtle hemodynamic alterations in cirrhosis.
Purpose
To assess the feasibility of measuring dynamic liver blood flow, perfusion, and T2* alterations in response to meal, hypercapnia, and hyperoxia challenges.
Study Type
Prospective.
Subjects
Ten healthy volunteers (HV) and 10 patients with compensated cirrhosis (CC).
Field Strength/Sequence
3T; phase contrast, arterial spin labeling, and normalT2* mapping.
Assessment
Dynamic changes in portal vein and hepatic artery blood flow (using phase contrast MRI), liver perfusion (using arterial spin labeling), and blood oxygenation (normalT2* mapping) following a meal challenge (660 kcal), hyperoxia (target PETO2 of 500 mmHg), and hypercapnia (target increase PETCO2 of ∼6 mmHg).
Statistical Tests
Tests between baseline and each challenge were performed using a paired two‐tailed t‐test (parametric) or Wilcoxon‐signed‐ranks test (nonparametric). Repeatability and reproducibility were determined by the coefficient of variation (CoV).
Results
Portal vein velocity increased following the meal (70 ± 9%, P < 0.001) and hypercapnic (7 (5–11)%, P = 0.029) challenge, while hepatic artery flow decreased (–30 ± 18%, P = 0.005) following the meal challenge in HV. In CC patients, portal vein velocity increased (37 ± 13%, P = 0.012) without the decrease in hepatic artery flow following the meal. In both groups, the meal increased liver perfusion (HV: 82 ± 50%, P < 0.0001; CC: 27 (16–42)%, P = 0.011) with faster arrival time of blood (HV: –54 (–56‐30)%, P = 0.074; CC: –42 ± 32%, P = 0.005). In HVs, normalT2* increased after the meal and in response to hyperoxia, with a decrease in hypercapnia (6 ± 8% P = 0.052; 3 ± 5%, P = 0.075; –5 ± 6%, P = 0.073, respectively), but no change in CC patients. Baseline between‐session CoV <15% for blood flow and <10% for normalT2* measures.
Data Conclusion
Dynamic changes in liver perfusion, blood flow, and oxygenation following a meal, hyperoxic, and hypercapnic challenges can be measured using noninvasive MRI and potentially be used to stratify patients with cirrhosis.
Level of Evidence: 2
Technical Efficacy: Stage 1
J. Magn. Reson. Imaging 2019;49:1577–1586.